RBC Capital analyst Ben Hendrix raised the firm’s price target on CVS Health (CVS) to $74 from $58 and keeps an Outperform ...
RBC Capital Markets maintained an Outperform rating on HubSpot Inc (NYSE:HUBS) and increased the price target to $950 from ...
RBC Capital markets adjusted their stance on Cochlear Ltd. (COH:AU) (OTC: CHEOY), a $10.9 billion medical device company ...
Brighthouse posted very strong Q4 earnings of $5.88 per share, beating the Zacks Consensus Estimate of $4.44 per share.
In a report released on February 11, Brian Abrahams from RBC Capital maintained a Buy rating on Corbus Pharmaceuticals (CRBP – Research ...
Pope John, now 11-5 on the season, advances to face familiar rival and top-seeded Camden Catholic final in the state final at ...
Following a record year for catastrophe bond issuance in 2024, the cat bond market remains strong, and according to analysts ...
In a report released yesterday, Conor McNamara from RBC Capital maintained a Buy rating on Bio-Rad Laboratories (BIO – Research Report), with a ...
Switch your mortgage to RBC and get up to $5,700 in value (up to $3,500 cash, a rebate in your switch fees of up to $1,100 and 55,000 Avion points). Terms and conditions apply. Offer available ...
RBC’s popular investment products include guaranteed investment certificates, or GICs. Not only do they offer highly competitive interest rates, but they also have flexible terms. Plus ...